Unofficial Proposal · Not the official Anterogen website
ANTEROGENFOR HUMAN TISSUE REGENERATION
KORCNContact

02 SCIENCE

Science & Technology

From adipose-derived mesenchymal stem cells
to formulations, clinical trials, and regulatory approval.

PLATFORM END-TO-END R&D

From Cells to Therapeutics

Connecting cell source selection, formulation research, clinical trials, and regulatory affairs.

  1. 01CELL SOURCE

    Adipose-derived MSC

    We design autologous and allogeneic cell therapy candidates based on adipose-derived mesenchymal stem cells.

  2. 02FORMULATION

    Scaffold & 3D culture

    We combine cells with scaffolds to expand into tissue engineering formulations tailored to the purpose, such as sheets and beads.

  3. 03TRANSLATION

    From R&D to approval

    We connect product and process development, efficacy evaluation, clinical trials, and regulatory approval into a unified development flow.

CELL SHEET CONCEPT

Cell sheets aspiring toward a ready-made form

A sheet-type formulation combining allogeneic adipose-derived mesenchymal stem cells with a biocompatible scaffold.

MHLWAlloStem Sheet Approval Information ↗

Conceptual image of a biocompatible scaffold and cell sheet on a culture dish

OUTPUTS RESEARCH RECORDS

Research Outcomes

Anterogen's research is carried forward through cosmetic ingredients, intellectual property, and scientific publications.